Fig. 9.
Sirtuin 1 (SIRT1) expression was evaluated in pancreatic cancer samples before and after chemotherapy. (a) SIRT1 expression in pancreatic cancer samples before chemotherapy (BC) and after chemotherapy (AC) (n = 8) was analyzed by immunohistochemical staining with an anti-SIRT1 antibody in paraffin-embedded tissue sections. (b) Representative expression of SIRT1 was analyzed in pancreatic cancer samples before (n = 4) and after chemotherapy (n = 4) by Western blot analysis. The β-actin level was assessed as a loading control. (c) Expression of SIRT1 was also detected in RNA levels by quantitative RT-PCR. Representative results are shown.